您现在的位置:首页更多保健食品技术研发
保健食品技术研发

欧盟评价一种4-植酸酶的安全性

发布时间:2019-10-30 浏览量:60
食品伙伴网讯  2019年10月17日,欧盟食品安全局EFSA)发布关于来自转基因菌株里氏木霉DP‐Nzt55的4-植酸酶(4‐phytase)安全性的评估结果。
据了解,这种食品酶旨在用于蒸馏酒精生产。经过评估,专家小组得出结论,这种食品酶在预期使用条件下不会引起安全问题。
部分原文报道如下:

The food enzyme 4‐α‐d‐glucan glucohydrolase (EC 3.2.1.3) is produced with a genetically modified Trichoderma reesei DP‐Nzh63 by Danisco US Inc. The genetic modifications do not give rise to safety concerns. The food enzyme is free from viable cells of the production organism and recombinant DNA. The glucan 1,4‐α‐glucosidase is intended to be used in distilled alcohol production. Since residual amounts of total organic solids are removed by distillation (> 99%), toxicological data were not considered necessary and dietary exposure was not calculated. Similarity of the amino acid sequence to those of known allergens was searched and no matches were found. The Panel considered that, under the intended conditions of use, the risk of allergic sensitisation and elicitation reactions by dietary exposure can be excluded. based on the data provided, the Panel concluded that this food enzyme does not give rise to safety concerns under the intended conditions of use.


文章来源:食品伙伴网

推荐新闻
X
1

QQ设置

3

SKYPE 设置

4

阿里旺旺设置

5

电话号码管理

6

二维码管理

展开